Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00371241 · ClinicalTrials.gov registry record
Antibody Secreting Cell and Cyotokine Profiles in Neonates on ECMO
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 12
- Enrollment target
NCT00371241 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 12 participants.
The verdict
NCT00371241 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
Infants are placed on ECMO for correction of reversible respiratory failure. Often, because a few of the reasons for respiratory failure show us similar things in the baby, it is difficult to determine exactly which is causing the biggest problem. We are now capable of measuring certain cells and proteins in these infants that may help us more accurately diagnose the exact problem. We hypothesize that infants placed on ECMO will show unique antibody-secreting cells responses and patterns of cytokine and chemokine (protein) response to illness and to the ECMO circuit. If we find unique patterns to these cells or proteins, they may be able to predict outcomes or guide treatment of these infants.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00371241
The ClinicalTrials.gov registry entry for NCT00371241 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00371241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00371241 about?
NCT00371241 is a clinical study titled "Antibody Secreting Cell and Cyotokine Profiles in Neonates on ECMO". Infants are placed on ECMO for correction of reversible respiratory failure. Often, because a few of the reasons for respiratory failure show us similar things in the baby, it is difficult to determine exactly which is causing the biggest problem. We are now capable of measuring certain cells and pr...
What is the current status of trial NCT00371241?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2006-09. Estimated completion is 2007-11.
Who is sponsoring clinical trial NCT00371241?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.